A Study to Evaluate the Relative Bioavailability of Povetacicept Formulations and Bioequivalence of Povetacicept Presentations

NCT07010406 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Povetacicept

Sponsor

Vertex Pharmaceuticals Incorporated